Amal Therapeutics
Florian Durante is a Financial Analyst and Financial Controller with extensive experience in the financial sector, currently holding positions at Boehringer Ingelheim since April 2022, where significant contributions include co-leading the financial integration of the acquisition of T3 Pharmaceutical AG and managing financial processes for various entities within the Innovation Unit. Durante's experience encompasses financial reporting, budgeting, and forecasting, along with compliance management and external collaboration oversight. Prior roles include accounting and HR-controlling positions at Bank CIC and Universitäre Psychiatrische Kliniken Basel, and a commercial apprenticeship at Syngenta. Educational credentials include a Master of Science in International Management and a Bachelor of Science in Business Administration from the University of Applied Sciences and Arts Northwestern Switzerland.
This person is not in any teams
This person is not in any offices
Amal Therapeutics
Amal Therapeutics is a Biotechnology company located in 64 av., de la Roseraie, 1205 Geneva, Switzerland.